Literature DB >> 12962751

Assessment of glomerular filtration rate in transplant recipients with severe renal insufficiency by Nankivell, Modification of Diet in Renal Disease (MDRD), and Cockroft-Gault equations.

E Rodrigo1, G Fernández-Fresnedo, J C Ruiz, C Piñera, M Heras, A L M de Francisco, S Sanz de Castro, J G Cotorruelo, J A Zubimendi, M Arias.   

Abstract

Measurement of glomerular filtration rate (GFR) is time consuming and cumbersome. Several formulas have been developed to predict creatinine clearance (CrCl) or GFR using serum creatinine (Cr) concentrations and demographic characteristics. However, few studies have been performed to discern the best formula to estimate GFR in kidney transplantation. In this study, Cockroft-Gault (CG), Nankivell, and Levey (MDRD) formulas were tested to predict GFR in 125 cadaveric renal transplant patients with severe renal insufficiency (GFR less than 30 mL/min per 1.73 m2). The GFR was estimated as the average Cr and urea clearances. The mean GFR estimated by averaged Cr and urea clearances (22.18+/-5.23 mL/min per 1.73 m2) was significantly different from the mean values yielded by the MDRD formula (20.42+/-6.65 mL/min per 1.73 m2, P=.000), the Nankivell formula (30.14+/-11.98 mL/min per 1.73 m2, P=.000), and the CG formula (29.42+/-8.64 mL/min per 1.73 m2, P=.000). The MDRD formula showed a better correlation (R=0.741, P=.000) than the CG (R=0.698, P=.000) and the Nankivell formulas (R=0.685, P=.000). Analysis of differences using the Bland-Altmann method demonstrated that MDRD gave the lowest bias (MDRD: -1.65+/-4.4 mL/min per 1.73 m2; CG: 7.33+/-6.24 mL/min per 1.73 m2; Nankivell: 8.05+/-9.23 mL/min per 1.73 m2) and narrower limits of agreement (Nankivell: -10.41-26.51 mL/min per 1.73 m2; CG: -5.15-19.81 mL/min per 1.73 m2; MDRD: -10.61-7.31 mL/min per 1.73 m2). In transplant patients with severe renal insufficiency, the MDRD equation seems better than the other formulas to estimate GFR.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12962751     DOI: 10.1016/s0041-1345(03)00625-0

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  8 in total

1.  Training alterations in elite cyclists may cause transient changes in glomerular filtration rate.

Authors:  Chad D Touchberry; Mark Ernsting; Greg Haff; J Lon Kilgore
Journal:  J Sports Sci Med       Date:  2004-11-01       Impact factor: 2.988

2.  Living-unrelated donor renal transplantation: an alternative to living-related donor transplantation?

Authors:  Nadeem Ahmad; Kamran Ahmed; Mohammad Shamim Khan; Francis Calder; Nizam Mamode; John Taylor; Geoff Koffman
Journal:  Ann R Coll Surg Engl       Date:  2008-04       Impact factor: 1.891

Review 3.  [Nephrogenic systemic fibrosis (NSF)--implications for radiology].

Authors:  H J Michaely; H S Thomsen; M F Reiser; S O Schoenberg
Journal:  Radiologe       Date:  2007-09       Impact factor: 0.635

4.  Population pharmacokinetics of ganciclovir in solid-organ transplant recipients receiving oral valganciclovir.

Authors:  N Perrottet; C Csajka; M Pascual; O Manuel; F Lamoth; P Meylan; J D Aubert; J P Venetz; P Soccal; L A Decosterd; J Biollaz; T Buclin
Journal:  Antimicrob Agents Chemother       Date:  2009-03-23       Impact factor: 5.191

5.  Factors influencing survival after kidney transplant failure.

Authors:  Jennifer A McCaughan; Christopher C Patterson; Alexander P Maxwell; Aisling E Courtney
Journal:  Transplant Res       Date:  2014-09-24

6.  Acute kidney injury secondary to urinary tract infection in kidney transplant recipients.

Authors:  Tomasz Królicki; Klaudia Bardowska; Tobiasz Kudla; Anna Królicka; Krzysztof Letachowicz; Oktawia Mazanowska; Wojciech Krajewski; Paweł Poznański; Magdalena Krajewska; Dorota Kamińska
Journal:  Sci Rep       Date:  2022-06-27       Impact factor: 4.996

7.  Modification of diet in renal disease and Cockraft-Gaultformula accuracy in glomerular filtration rate estimation in Iranian adults.

Authors:  Abdolamir Atapour; Kalantari Elham; Shahrzad Shahidi; Mojgan Mortazavi Najafabadi; Parin Hedayati
Journal:  Adv Biomed Res       Date:  2013-03-14

8.  Design and rationale of the ATHENA study--A 12-month, multicentre, prospective study evaluating the outcomes of a de novo everolimus-based regimen in combination with reduced cyclosporine or tacrolimus versus a standard regimen in kidney transplant patients: study protocol for a randomised controlled trial.

Authors:  Claudia Sommerer; Barbara Suwelack; Duska Dragun; Peter Schenker; Ingeborg A Hauser; Björn Nashan; Friedrich Thaiss
Journal:  Trials       Date:  2016-02-17       Impact factor: 2.279

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.